An update from Streamline Health Solutions (STRM) is now available.
Streamline Health Solutions, Inc. announced its fiscal results for Q4 2023 and the full year ending January 31, 2024, while also addressing concerns over its Nasdaq listing due to its stock price falling below the minimum bid requirement. The company has been granted an additional 180 days to meet Nasdaq’s standards. Additionally, they have appointed Bryant J. Reeves, III as the permanent Chief Financial Officer, with a salary increase and a restricted stock award, and have also increased the salary and granted restricted stock to their CEO, Benjamin L. Stilwill.
See more insights into STRM stock on TipRanks’ Stock Analysis page.
